The Influence of Sildenafil–Metformin Combination on Hyperalgesia and Biochemical Markers in Diabetic Neuropathy in Mice

• Published in: Medicina (Kaunas, Lithuania) Vol. 59; no. 8; p. 1375
• Main Authors: Pușcașu, Ciprian, Ungurianu, Anca, Șeremet, Oana Cristina, Andrei, Corina, Mihai, Dragoș Paul, Negreș, Simona
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 27.07.2023; MDPI
• Subjects: Antidiabetics; antihyperalgesic; Bioethics; Blood sugar; Blood vessels; Chronic illnesses; Chronic pain; combination; Cytokines; Diabetes; Diabetic neuropathies; Diabetic neuropathy; Drug withdrawal; Glucose; Health aspects; Hyperalgesia; Kinases; Metabolism; Metformin; Narcotics; Nitric oxide; Pathology; Pathophysiology; Pharmacy; Sildenafil; Tumor necrosis factor; Tumor necrosis factor-TNF; Type 2 diabetes; Canada; Germany; Romania; Bucharest Romania; Hungary
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina59081375

Background and objectives: Worldwide, approximately 500 million people suffer from diabetes and at least 50% of these people develop neuropathy. Currently, therapeutic strategies for reducing diabetic neuropathy (DN)-associated pain are limited and have several side effects. The purpose of the study was to evaluate the antihyperalgesic action of different sildenafil (phosphodiesterase-5 inhibitor) and metformin (antihyperglycemic agent) combinations in alloxan-induced DN. Methods: The study included 100 diabetic mice and 20 non-diabetic mice that were subjected to hot and cold stimulus tests. Furthermore, we determined the influence of this combination on TNF-α, IL-6 and nitrites levels in brain and liver tissues. Results: In both the hot-plate and tail withdrawal test, all sildenafil–metformin combinations administered in our study showed a significant increase in pain reaction latencies when compared to the diabetic control group. Furthermore, all combinations decreased blood glucose levels due to the hypoglycemic effect of metformin. Additionally, changes in nitrite levels and pro-inflammatory cytokines (TNF-α and IL-6) were observed after 14 days of treatment with different sildenafil–metformin combinations. Conclusions: The combination of these two substances increased the pain reaction latency of diabetic animals in a dose-dependent manner. Moreover, all sildenafil–metformin combinations significantly reduced the concentration of nitrites in the brain and liver, which are final products formed under the action of iNOS.